Results 151 to 160 of about 5,138,951 (296)

Neuroprotective Effect of Remote Ischemic Conditioning on Patients Undergoing Intravenous Thrombolysis: A Randomized Controlled Trial

open access: yesMedComm, Volume 7, Issue 4, April 2026.
Adjunctive remote ischemic conditioning (RIC) administered twice within 24 h after intravenous thrombolysis (IVT) improved cerebral autoregulation, suggesting that RIC exerted neuroprotective effects in patients undergoing IVT. ABSTRACT Intravenous thrombolysis (IVT) is the treatment with the highest level of evidence for acute ischemic stroke, but ...
Shuang Qi   +11 more
wiley   +1 more source

Heterogeneity of Treatment Effect for Intra‐Aortic Balloon Pump Use Across Lactate Trajectories in Cardiogenic Shock Patients Supported by VA‐ECMO: An Analysis of the Chinese Extracorporeal Life Support Registry

open access: yesMedComm, Volume 7, Issue 4, April 2026.
Lactate trajectories can stratify the mortality risk in patients with acute myocardial infarction‐related cardiogenic shock receiving VA‐ECMO and reflect heterogeneity of treatment effect for intra‐aortic balloon pump. ABSTRACT This study aimed to investigate the heterogeneity of treatment effect for intra‐aortic balloon pump (IABP) across various ...
Xiang‐Jie Duan   +9 more
wiley   +1 more source

Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.

open access: yesJournal of the American College of Cardiology, 2017
S. Konstantinides   +27 more
semanticscholar   +1 more source

Blood–Brain Barrier: Structure, Function, Diseases, and Drug Delivery Systems

open access: yesMedComm, Volume 7, Issue 4, April 2026.
This graphical abstract illustrates how blood–brain barrier‐targeted nanomedicine integrates diverse nanocarrier platforms with mechanism‐based therapeutic strategies to overcome delivery barriers in ischemic stroke, enabling targeted modulation of oxidative stress, inflammation, excitotoxicity, and neuronal survival.
Yanan He   +10 more
wiley   +1 more source

Non-administration of thrombolytic agents in acute myocardial infarction patients in Hajar hospital, Shahrekord, Iran: prevalence rate and causes

open access: yesARYA Atherosclerosis, 2013
BACKGROUND: Cardiovascular diseases are the major causes of mortality worldwide and acute myocardial infarction (AMI) is the leading cause of mortality among cardiovascular diseases. Thrombolytic therapies, especially during the first few hours after the
Mohammadreza Samieinasab   +4 more
doaj  

Analysis of the Phenotype and Gene Mutations of Two Families With Combined Mutations of Anticoagulant Protein Genes

open access: yesMolecular Genetics &Genomic Medicine, Volume 14, Issue 4, April 2026.
In these two pedigrees, we identified distinct mutations in the AT and PC genes. Individuals harboring both mutations exhibited a significantly higher incidence of venous thrombosis. ABSTRACT Background AT and PC are key components of the anticoagulant system. Mutations in their encoding genes, SERPINC1 and PROC, can lead to insufficient protein levels
Yueli Guo   +5 more
wiley   +1 more source

Thrombolytic Therapy

open access: yesNew England Journal of Medicine, 1982
Jan Koch-Weser   +4 more
openaire   +4 more sources

Right Atrial Thrombus in Transit: A Case of Spontaneous Embolisation Captured Across Echocardiography

open access: yesRespirology Case Reports, Volume 14, Issue 4, April 2026.
In this report, we describe a large RA thrombus in transit captured sequentially across multiple imaging modalities. This case highlights how quickly these thrombi can evolve and emphasises the need for individualised decision‐making when standard interventions are limited by clinical context.
Abdullah Al Qaraghuli   +7 more
wiley   +1 more source

Recent advances in intra-arterial thrombolysis

open access: yesAnnals of Indian Academy of Neurology, 2008
Thrombolytic therapy has revolutionized acute ischemic stroke (AIS) treatment; however it is clear that intravenous (IV) thrombolytic therapy has certain limitations, including a short-time window for use, poor specificity for the site of arterial ...
Bershad Eric, Suarez Jose
doaj  

Rhesus Antagonism Is Associated With Non‐Anastomotic Biliary Strictures After Orthotopic Liver Transplantation From Brain‐Death Donors

open access: yesClinical Transplantation, Volume 40, Issue 4, April 2026.
ABSTRACT Background Biliary non‐anastomotic strictures (NAS) are among the most severe complications of liver transplantation (LT). Risk factors include donation after circulatory death (DCD) as compared to donation after brain death (DBD) and prolonged ischemia times.
Leonard D. (Niels) Broekman   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy